Sylvamo
SLVM
31.77
-1.14
-3.46%
Sylvamo
US · SLVM
#3074 by market cap
Listed 2021
31.77
-1.14
-3.46%
Live - 5344 symbols - heartbeat 280s ago
· 2026-10-08 07:00
Pre-market
31.61
-0.50%
After-hours
31.77
0.00%
- Market cap
- 1.26B
- P/E (TTM)i
- 16.99
- P/Bi
- 1.32
- EPSi
- 3.24
- Div yieldi
- 7.08%
- 52W posi
- 2%
Reader sentiment
Are you bullish or bearish on SLVM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.36, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -11.18% YoY
Margins
- Gross margin
- 21.93%
- Operating margin
- 7.43%
- Net margin
- 3.94%
Key ratios & quality
- Enterprise valuei
- 1.98B
- PEG ratioi
- 4.46
- Altman Z-Scorei
- 3.36
PEG uses trailing P/E against the 3-year net income growth rate (3.81%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.12B | 4.02B | 2.39B | 2.83B | 3.63B | 3.72B | 3.77B | 3.35B |
| Gross profit | 1.50B | 1.38B | 456.00M | 685.00M | 1.01B | 912.00M | 940.00M | 735.00M |
| Selling & admin expenses | 696.00M | 655.00M | 202.00M | 207.00M | 325.00M | 343.00M | 311.00M | 281.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 570.00M | 499.00M | 91.00M | 327.00M | 536.00M | 403.00M | 444.00M | 249.00M |
| Pretax profit | 573.00M | 502.00M | 95.00M | 328.00M | 467.00M | 369.00M | 405.00M | 199.00M |
| Tax | 154.00M | 125.00M | 8.00M | 101.00M | 131.00M | 116.00M | 103.00M | 67.00M |
| Net profit | 419.00M | 377.00M | 170.00M | 331.00M | 118.00M | 253.00M | 302.00M | 132.00M |
| Basic EPS | 9 | 9 | 4 | 8 | 3 | 6 | 7 | 3 |
| Diluted EPS | 9.47 | 8.59 | 3.87 | 7.53 | 2.66 | 5.93 | 7.18 | 3.24 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 821.00M | 794.00M | 846.00M | 890.00M | 755.00M | 806.00M |
| Gross profit | 159.00M | 154.00M | 222.00M | 200.00M | 125.00M | 132.00M |
| Selling & admin expenses | 73.00M | 72.00M | 68.00M | 68.00M | 73.00M | 69.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 42.00M | 30.00M | 97.00M | 80.00M | 3.00M | 12.00M |
| Pretax profit | 33.00M | 20.00M | 88.00M | 58.00M | -6.00M | 1.00M |
| Tax | 6.00M | 5.00M | 31.00M | 25.00M | -3.00M | 12.00M |
| Net profit | 27.00M | 15.00M | 57.00M | 33.00M | -3.00M | -11.00M |
| Basic EPS | 1 | 0 | 1 | 1 | 0 | 0 |
| Diluted EPS | 0.65 | 0.37 | 1.41 | 0.83 | -0.08 | -0.28 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | -- | 1.39B | 1.12B | 1.11B | 1.24B | 1.19B | 1.06B | 1.08B |
| Cash & ST investments | -- | 135.00M | 95.00M | 159.00M | 360.00M | 220.00M | 205.00M | 135.00M |
| Inventory | -- | 443.00M | 342.00M | 279.00M | 364.00M | 404.00M | 361.00M | 418.00M |
| Total assets | -- | 3.47B | 2.91B | 2.60B | 2.71B | 2.87B | 2.60B | 2.76B |
| Total current liabilities | -- | 580.00M | 490.00M | 758.00M | 728.00M | 695.00M | 682.00M | 716.00M |
| Short-term debt | -- | 9.00M | 4.00M | 41.00M | 29.00M | 28.00M | 22.00M | 90.00M |
| Long-term debt | -- | 25.00M | 22.00M | 1.36B | 1.00B | 931.00M | 782.00M | 763.00M |
| Total liabilities | -- | 953,000,000.00 | 799,000,000.00 | 2,415,000,000.00 | 2,032,000,000.00 | 1,971,000,000.00 | 1,757,000,000.00 | 1,797,000,000.00 |
| Total equity | -- | 2.52B | 2.11B | 182.00M | 678.00M | 901.00M | 847.00M | 966.00M |
| Retained earnings | -- | -- | 0 | 1.94B | 2.03B | 2.22B | 2.46B | 2.51B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.01B | 977.00M | 990.00M | 1.08B | 1.10B | 1.11B |
| Cash & ST investments | 154.00M | 113.00M | 94.00M | 135.00M | 130.00M | 123.00M |
| Inventory | 372.00M | 396.00M | 434.00M | 418.00M | 483.00M | 503.00M |
| Total assets | 2.63B | 2.67B | 2.70B | 2.76B | 2.83B | 2.88B |
| Total current liabilities | 616.00M | 635.00M | 653.00M | 716.00M | 758.00M | 752.00M |
| Short-term debt | 23.00M | 46.00M | 30.00M | 90.00M | 155.00M | 121.00M |
| Long-term debt | 794.00M | 767.00M | 778.00M | 763.00M | 766.00M | 843.00M |
| Total liabilities | 1,721,000,000.00 | 1,709,000,000.00 | 1,726,000,000.00 | 1,797,000,000.00 | 1,855,000,000.00 | 1,920,000,000.00 |
| Total equity | 908.00M | 959.00M | 977.00M | 966.00M | 979.00M | 955.00M |
| Retained earnings | 2.46B | 2.46B | 2.50B | 2.51B | 2.49B | 2.46B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 589.00M | 524.00M | 359.00M | 549.00M | 438.00M | 504.00M | 469.00M | 268.00M |
| Depreciation & amortization | 198.00M | 192.00M | 135.00M | 126.00M | 125.00M | 143.00M | 159.00M | 179.00M |
| Free cash flow | 439.00M | 406.00M | 293.00M | 480.00M | 289.00M | 294.00M | 248.00M | 44.00M |
| Dividends paid | -- | -- | 0 | 0 | -10.00M | -57.00M | -62.00M | -73.00M |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -80.00M | -70.00M | -69.00M | -82.00M |
| Ending cash balance | 175.00M | 135.00M | 70.00M | 159.00M | 360.00M | 280.00M | 205.00M | 135.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 23.00M | 64.00M | 87.00M | 94.00M | -10.00M | 38.00M |
| Depreciation & amortization | 40.00M | 45.00M | 49.00M | 45.00M | 41.00M | 43.00M |
| Free cash flow | -25.00M | -2.00M | 33.00M | 38.00M | -59.00M | -23.00M |
| Dividends paid | -18.00M | -18.00M | -19.00M | -18.00M | -18.00M | -18.00M |
| Stock buybacks / issuance | -20.00M | -20.00M | -42.00M | 0 | 0 | 0 |
| Ending cash balance | 154.00M | 113.00M | 94.00M | 135.00M | 130.00M | 123.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | 14.98 | 7.35 | 28.86 | 27.44 | 32.05 | 34.55 | 14.56 |
| ROA %i | -- | 10.86 | 5.33 | 12.02 | 4.45 | 9.06 | 11.03 | 4.92 |
| ROIC %i | -- | 14.51 | 7.25 | 17.72 | 10.19 | 15.49 | 18.87 | 9.09 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | 22.13 | 26.05 | 27.49 |
| EBIT margin %i | 13.84 | 12.60 | 6.45 | 14.02 | 14.99 | 11.53 | 12.14 | 7.28 |
| FCF / sales %i | 10.66 | 10.11 | 9.44 | 13.51 | 7.97 | 7.90 | 6.57 | 1.31 |
| Current ratioi | -- | 2.40 | 2.28 | 1.46 | 1.71 | 1.72 | 1.56 | 1.50 |
| Quick ratioi | -- | 1.46 | 1.51 | 0.77 | 1.15 | 0.97 | 0.97 | 0.81 |
| Debt / assetsi | -- | 0.98 | 0.89 | 53.83 | 38.08 | 33.39 | 30.88 | 30.87 |
| LT debt / equityi | -- | 0.99 | 1.04 | 745.60 | 147.94 | 103.33 | 92.33 | 78.99 |
| Interest coveragei | -- | 126.50 | -- | 15.84 | 7.06 | 7.15 | 8.64 | 5.42 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -11.78 | -3.34 | 15.98 | 10.09 | -2.61 |
| Net income CAGR (3Y) %i | -- | -- | -- | -7.56 | -32.10 | 14.17 | -3.01 | 3.81 |
| FCF CAGR (3Y) %i | -- | -- | -- | 3.02 | -10.71 | 0.11 | -19.76 | -46.60 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 31.83 | 24.37 | 18.81 | 14.56 | 10.81 | 7.94 |
| ROA %i | 10.54 | 8.14 | 6.47 | 4.92 | 3.73 | 2.74 |
| ROIC %i | 17.71 | 14.11 | 9.87 | 9.09 | 7.00 | 5.42 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.63 | 9.44 | 8.60 | 7.28 | 6.24 | 5.70 |
| FCF / sales %i | 6.94 | 5.41 | 3.09 | 1.31 | 0.30 | -- |
| Current ratioi | 1.64 | 1.54 | 1.52 | 1.50 | 1.45 | 1.47 |
| Quick ratioi | 0.97 | 0.81 | 0.77 | 0.81 | 0.70 | 0.68 |
| Debt / assetsi | 31.08 | 30.47 | 29.89 | 30.87 | 32.50 | 33.53 |
| LT debt / equityi | 87.44 | 79.98 | 79.63 | 78.99 | 78.24 | 88.27 |
| Interest coveragei | 8.41 | 6.70 | -- | 5.42 | 4.56 | 4.00 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Uncoated Papers is the largest reported line at 94.17% of revenue, across 2 reported segments.
- The next-largest line, Market Pulp, is a distant second at 5.83% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Uncoated Papers94.17%
Market Pulp5.83%
Quote time 2026-10-08 07:00:16 · For reference only, not investment advice and not tailored to your situation.